XHKG
86618
Market cap14bUSD
Oct 09, Last price
36.08HKD
1D
2.04%
1Q
-3.27%
IPO
-67.84%
Name
JD Health International Inc
Chart & performance
P/E
18.38
P/S
1.35
EPS
1.67
Div yield, %
—
Shrs. gr., 5y
7.67%
Rev. gr., 5y
30.53%
Revenues
73.44b
+26.28%
Net income
5.38b
+29.16%
CFO
9.94b
+129.34%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Related entities
Subsidiaries
JD Health (HK) Limited
Key people
Non-Executive Chairman of the Board · since 2020
Hui Deng
Chief Financial Officer · since 2023
Company Secretary
Independent Non-Executive Director · since 2020
George Lau
Independent Non-Executive Director · since 2024
Ling Li
Independent Non-Executive Director · since 2020
Independent Non-Executive Director · since 2022
Jiyu Zhang
Independent Non-Executive Director · since 2021
Legal address
C/O MAPLES CORPORATE SERVICES LIMITMED
PO BOX 309
UGLAND HOUSE
GRAND CAYMAN
GEORGE TOWN KY1-1104
KY
PO BOX 309
UGLAND HOUSE
GRAND CAYMAN
GEORGE TOWN KY1-1104
KY
Headquarters
京东总部大厦
亦庄经济开发区科创十一街18号
北京, BJ 100000
CN
亦庄经济开发区科创十一街18号
北京, BJ 100000
CN
Address
18A JD BUILDING
YIZHUANG ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE
BEIJING, BJ 100000
CN
YIZHUANG ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE
BEIJING, BJ 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||